Navegar

Colección

Datos Estadísticas

Lista de

Carcinoma, Non-Small-Cell Lung
8
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model" (2017) Marostica, L.L.;de Barros, A.L.B.;Oliveira, J. (...)Simões, C.M.O. Toxicology and Applied Pharmacology. 329:272-281
"Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549" (2016) Silva, I.T.;Geller, F.C.;Persich, L. (...)Simões, C.M.O. Investigational New Drugs. 34(2):139-148
"In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B" (2015) Silva, I.T.;Carvalho, A.;Lang, K.L. (...)Ludwig, S. PLoS ONE. 10(2)
"In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B" (2015) Silva, I.T.;Carvalho, A.;Lang, K.L. (...)Ludwig, S. PLoS ONE. 10(2)
"Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data" (2012) Degese, M.S.;Mendizabal, J.E.;Gandini, N.A. (...)Facchinetti, M.M. Lung Cancer. 77(1):168-175
"Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance" (2010) Carlini, M.J.;Dalurzo, M.C.L.;Lastiri, J.M. (...)Lauría de Cidre, L.S. Human Pathology. 41(5):697-705